Alpine Global Management, LLC Silverback Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
N/A
23,435 New
23,435 $0
Q4 2021

Feb 14, 2022
SELL
$6.03 - $11.67 $99,899 - $193,336
-16,567 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$9.98 - $35.22 $165,338 - $583,489
16,567 New
16,567 $364,000

Others Institutions Holding SBTX

# of Institutions
163
Shares Held
62.7M
Call Options Held
872K
Put Options Held
589K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email